AIM ImmunoTech Inc.
AIM
$0.23
$0.00-0.26%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.27M | -13.28M | -13.96M | -15.75M | -16.17M |
| Total Depreciation and Amortization | 668.00K | 459.00K | 474.00K | 495.00K | 504.00K |
| Total Amortization of Deferred Charges | 369.00K | 488.00K | 369.00K | 138.00K | 31.00K |
| Total Other Non-Cash Items | 2.90M | 3.17M | 3.04M | 1.53M | 1.30M |
| Change in Net Operating Assets | -4.04M | -2.16M | -878.00K | 662.00K | 3.37M |
| Cash from Operations | -14.37M | -11.32M | -10.96M | -12.93M | -10.96M |
| Capital Expenditure | -- | -- | -- | 0.00 | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.00K | 918.00K | 1.85M | 5.65M | 5.71M |
| Cash from Investing | 52.00K | 918.00K | 1.85M | 5.65M | 5.69M |
| Total Debt Issued | 2.50M | 2.75M | 2.75M | 250.00K | 383.00K |
| Total Debt Repaid | -1.48M | -860.00K | -660.00K | -911.00K | -251.00K |
| Issuance of Common Stock | 22.11M | 11.18M | 7.68M | 7.71M | 801.00K |
| Repurchase of Common Stock | -6.70M | -6.70M | -6.70M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.31M | 8.94M | 7.31M | 1.65M | 1.26M |
| Cash from Financing | 23.75M | 15.32M | 10.39M | 8.71M | 2.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.42M | 4.92M | 1.28M | 1.43M | -3.08M |